Avapro II Salt Study


Study Description: Avapro is an angiotensin receptor-blocking agent that has been approved by the Food and Drug Administration (FDA) to treat hypertension (high blood pressure). However in this study, we are looking at how Avapro affects sodium retention, blood pressure and a particular hormone called Angiotensin II following stress. This is a double blind study whereupon each participant will be testing twice; during week one of testing they will take either Avapro or a placebo (sugarpill) and the second week they will take the opposite of what they took the first week. Half of the participants will be diagnosed as being normotensive (normal blood pressure) and the other half will be diagnosed as being pre-hypertensive, but not on any blood pressure medication.

Contact for Enrollment

    
     (706) 721-1755
    knorland@gru.edu

    Submit Information Online

Principal Investigator: Gregory Harshfield

Eligibility Criteria: * African American (male or female) * Ages 18-50 * Have a BMI (Body Mass Index) rate of 25 kg/m2 or higher * Not on any prescription medication * Not pregnant

Compensation: Yes, subjects will be compensated.

Compensation Explanation: SUBJECT PAYMENT Payment will be made using a pre-paid debit card. It works like a bank debit card. We will give you a debit card and each time you receive a payment for participation in this study, the money will be added to the card after each completed visit. You may use this card at any store that accepts credit cards or you can use a bank machine to remove cash. However, there may be fees drawn against the balance of the card for cash withdrawals and inactivity. You will receive letters with additional information on how you can use this card and who to call if you have any questions. Be sure to read these letters, including the cardholder agreement, for details about fees. The debit card system is administered by an outside company. The company, Greenphire, will be given your name and social security number. They will use this information only as part of the payment system. Your information will not be used for any other purposes and will not be given or sold to any other company. Greenphire will not receive any information about your health status or the study in which you are participating. For completing the screening visit, which includes all aspects of the screening described above, you will receive $20.00 which will be added to your debit card. For participating in the testing protocol, you will receive $200.00 for both 7-day testing week for a total of $400.00. In addition to the $400.00, you can earn an extra $20.00 if you win the video game challenge. Since you get to play the video game twice, you could possibly earn $20.00 per testing visit. You will also earn $20.00 more for completing the DEXA/pQCT scans. You can be compensated up to a grand total of $480.00. You will be compensated after each testing visit and the amount due to you will be added to your debit card. You need to understand that you must complete each testing visit in order to be paid. Completion of Screening Visit?????????$20.00 ? Debit Card Completion of Test Week One???? ????$200.00 ? Debit Card Win Video Game of Week One ????????..$20.00 ? Debit Card Completion of Test Week Two??? ???........$200.00 ? Debit Card Win Video Game of Week Two ??? ????. $20.00 - Debit Card Completion of DEXA/pQCT Scans..............................$20.00 - Debit Card _____________________ ________ Grand Total: $480.00 If you are receiving compensation over $100.00 from participating in this study, you will be required to complete a W-9 form. If you are an Augusta University employee, payment will be included in your payroll check. This payment will be subject to Federal and Georgia state withholding taxes as well as FICA tax and will reflect on the W-2 form at calendar year end. Payment received as compensation for participation in research is considered taxable income to the research participant. If payment to an individual exceeds $600 in any one calendar year, Augusta University is required by law to report this information to the Internal Revenue Service (IRS). Research participant payments to a non-employee of AU exceeding $600 during any calendar year will result in a 1099 (Miscellaneous Income) form being issued to the individual and a copy sent to the IRS.

 

Didn't find a study to participate in?

If you don't see specific studies that interest you, please submit your contact information for future studies.